NEJM Evidence

NEJM Evidence, a monthly digital journal from NEJM Group, presents innovative original research and fresh, bold ideas in clinical trial design and clinical decision-making.

Publisher
NEJM Group
Website
https://evidence.nejm.org/

Some content from Wikipedia, licensed under CC BY-SA

Diseases, Conditions, Syndromes

Q&A with physician-scientist on decoding early Lyme disease

Every year in the United States, an estimated 476,000 people are diagnosed and treated for Lyme disease. The estimate comes from the U.S. Centers for Disease Control and Prevention (CDC).